Target type: biologicalprocess
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of a protein at the postsynapse. [PMID:17062563]
Regulation of protein catabolic process at the postsynapse is a complex and vital biological process that plays a key role in neuronal plasticity, synaptic strength, and the overall functioning of the nervous system. It involves a precise orchestration of molecular events that control the breakdown of proteins at the postsynaptic density, a specialized structure on the receiving neuron that houses receptors and signaling molecules.
At the postsynapse, protein catabolism is tightly regulated by various mechanisms, including:
1. **Ubiquitination:** This process involves the attachment of ubiquitin, a small protein, to target proteins, marking them for degradation. Ubiquitin ligases, enzymes that catalyze this process, are often localized to the postsynaptic density and their activity is regulated by synaptic activity.
2. **Proteasome-mediated degradation:** The proteasome, a large protein complex, is the primary machinery for protein breakdown in eukaryotic cells. Ubiquitinated proteins are recognized by the proteasome and degraded into short peptides. Proteasome activity at the postsynapse is influenced by signaling pathways activated by neurotransmitters, such as glutamate.
3. **Lysosomal degradation:** Lysosomes, organelles containing hydrolytic enzymes, also contribute to protein degradation at the postsynapse. Lysosomes can engulf and degrade proteins directly or receive proteins delivered by autophagy, a process where portions of the cytoplasm are enclosed in vesicles and transported to lysosomes for degradation.
4. **Calcium-dependent proteolysis:** Calcium ions, a ubiquitous second messenger in neurons, can activate specific proteases that cleave proteins at the postsynapse. These proteases, such as calpains, play a role in regulating the activity of key synaptic proteins.
The regulation of protein catabolic processes at the postsynapse is critical for several reasons:
* **Synaptic plasticity:** Protein degradation is essential for modifying the composition of the postsynaptic density, a process that underlies synaptic plasticity, the ability of synapses to change their strength in response to neural activity.
* **Synaptic strength:** By removing unnecessary or damaged proteins, protein degradation helps maintain the integrity and function of the postsynaptic density, ensuring proper synaptic transmission.
* **Neural development:** Protein catabolic processes are involved in the formation and refinement of synapses during development.
* **Homeostasis:** Protein degradation contributes to the maintenance of cellular homeostasis by removing misfolded or damaged proteins that could disrupt normal function.
Dysregulation of protein catabolic processes at the postsynapse can lead to various neurological disorders, including neurodegenerative diseases, mental illnesses, and developmental disabilities. Understanding the intricate mechanisms involved in this process is therefore crucial for developing therapies for these conditions.
In summary, the regulation of protein catabolic processes at the postsynapse is a complex and multifaceted process that is critical for normal brain function. It involves a precise balance of ubiquitination, proteasome-mediated degradation, lysosomal degradation, and calcium-dependent proteolysis, all of which are tightly regulated by synaptic activity and signaling pathways.'
"
Protein | Definition | Taxonomy |
---|---|---|
Egl nine homolog 1 | An egl nine homolog 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9GZT9] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
alpha-ketoglutaric acid | 2-oxoglutaric acid : An oxo dicarboxylic acid that consists of glutaric acid bearing an oxo substituent at position 2. It is an intermediate metabolite in Krebs cycle. | oxo dicarboxylic acid | fundamental metabolite |
succinic acid | succinic acid : An alpha,omega-dicarboxylic acid resulting from the formal oxidation of each of the terminal methyl groups of butane to the corresponding carboxy group. It is an intermediate metabolite in the citric acid cycle. Succinic Acid: A water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. (Hawley's Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851) | alpha,omega-dicarboxylic acid; C4-dicarboxylic acid | anti-ulcer drug; fundamental metabolite; micronutrient; nutraceutical; radiation protective agent |
isocitric acid | isocitric acid : A tricarboxylic acid that is propan-1-ol with a hydrogen at each of the 3 carbon positions replaced by a carboxy group. isocitric acid: RN given refers to unlabeled parent cpd | secondary alcohol; tricarboxylic acid | fundamental metabolite |
succinylacetone | 4,6-dioxoheptanoic acid : A dioxo monocarboxylic acid that is heptanoic acid in which oxo groups replace the hydrogens at positions 4 and 6. It is an abnormal metabolite of the tyrosine metabolic pathway and a marker for type 1 tyrosinaemia. succinylacetone: inhibitor of heme biosynthesis | beta-diketone; dioxo monocarboxylic acid | human metabolite |
2,5-pyridinedicarboxylic acid | 2,5-Pyridinedicarboxylic acid: RN given refers to parent cpd isocinchomeronic acid : A pyridinedicarboxylic acid carrying carboxy groups at positions 2 and 5. | pyridinedicarboxylic acid | |
glycyrrhetinic acid | cyclic terpene ketone; hydroxy monocarboxylic acid; pentacyclic triterpenoid | immunomodulator; plant metabolite | |
2,4-pyridinedicarboxylic acid | lutidinic acid : A pyridinedicarboxylic acid carrying carboxy groups at positions 2 and 4. | pyridinedicarboxylic acid | |
oleanolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | plant metabolite | |
daminozide | daminozide: induces tumors | straight-chain fatty acid | |
ursolic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | geroprotector; plant metabolite | |
betulinic acid | hydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-HIV agent; anti-inflammatory agent; antimalarial; antineoplastic agent; EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor; plant metabolite | |
maslinic acid | (2Alpha,3beta)-2,3-dihydroxyolean-12-en-28-oic acid: from Luehea divaricata and Agrimonia eupatoria | dihydroxy monocarboxylic acid; pentacyclic triterpenoid | anti-inflammatory agent; antineoplastic agent; antioxidant; plant metabolite |
fumaric acid | fumaric acid : A butenedioic acid in which the C=C double bond has E geometry. It is an intermediate metabolite in the citric acid cycle. fumaric acid: see also record for ferrous fumarate; use FUMARATES for general fumaric acid esters | butenedioic acid | food acidity regulator; fundamental metabolite; geroprotector |
5-carboxy-8-hydroxyquinoline | 5-carboxy-8-hydroxyquinoline: a JmjC histone demethylase inhibitor; structure in first source | quinolines | |
oxalylglycine | N-oxalylglycine : An amino dicarboxylic acid that is iminodiacetic acid with an oxo substituent. It is used as an inhibitor of alpha-ketoglutarate dependent (EC 1.14.11.*) enzymes. oxalylglycine: structure given in first source | amino dicarboxylic acid; N-acylglycine | EC 1.14.11.* (oxidoreductase acting on paired donors, 2-oxoglutarate as one donor, incorporating 1 atom each of oxygen into both donors) inhibitor |
fg-4592 | roxadustat : An N-acylglycine resulting from the formal condensation of the amino group of glycine with the carboxy group of 4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxylic acid. It is an inhibitor of hypoxia inducible factor prolyl hydroxylase (HIF-PH). roxadustat: structure in first source | aromatic ether; isoquinolines; N-acylglycine | EC 1.14.11.2 (procollagen-proline dioxygenase) inhibitor; EC 1.14.11.29 (hypoxia-inducible factor-proline dioxygenase) inhibitor |
jnj 42041935 | |||
ascorbic acid | Ascorbic Acid: A six carbon compound related to glucose. It is found naturally in citrus fruits and many vegetables. Ascorbic acid is an essential nutrient in human diets, and necessary to maintain connective tissue and bone. Its biologically active form, vitamin C, functions as a reducing agent and coenzyme in several metabolic pathways. Vitamin C is considered an antioxidant. L-ascorbate : The L-enantiomer of ascorbate and conjugate base of L-ascorbic acid, arising from selective deprotonation of the 3-hydroxy group. Required for a range of essential metabolic reactions in all animals and plants. L-ascorbic acid : The L-enantiomer of ascorbic acid and conjugate acid of L-ascorbate. vitamin C : Any member of a group of vitamers that belong to the chemical structural class called butenolides that exhibit biological activity against vitamin C deficiency in animals. The vitamers include L-ascorbic acid and its salt, ionized and oxidized forms. | ascorbic acid; vitamin C | coenzyme; cofactor; flour treatment agent; food antioxidant; food colour retention agent; geroprotector; plant metabolite; skin lightening agent |
2-[[[4-hydroxy-2-oxo-1-(phenylmethyl)-3-quinolinyl]-oxomethyl]amino]acetic acid | quinolines | ||
bay 85-3934 | |||
gsk1278863 | daprodustat : A member of the class of barbiturates that is barbituric acid substituted by cyclohexyl groups at positions 1 and 3, and by a (carboxymethyl)aminocarbonyl group at position 5. It is an inhibitor of hypoxia-inducible factor prolyl hydroxylase developed by GlaxoSmithKline for the treatment of anaemia in patients with chronic kidney disease. GSK1278863: a HIF prolyl hydroxylase inhibitor |